Safety and Efficacy of Lenabasum at 21 Months in an Open-Label Extension of a Phase 2 Study in Diffuse Cutaneous Systemic Sclerosis Subjects

被引：0

作者：

Spiera, Robert ^{[1
]}

Hummers, Laura ^{[2
]}

Chung, Lorinda

Frech, Tracy ^{[3
,4
]}

Domsic, Robyn ^{[5
]}

Hsu, Vivien ^{[6
]}

Furst, Daniel ^{[7
]}

Gordon, Jessica ^{[1
]}

Myers, Madeline ^{[8
]}

Simms, Robert W. ^{[9
]}

Lee, Elizabeth ^{[10
]}

Constantine, Scott ^{[10
]}

Dgetluck, Nancy ^{[10
]}

Bloom, Bradley ^{[10
]}

White, Barbara ^{[10
]}

机构：

[1] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA

[2] Johns Hopkins Univ, Div Rheumatol, Sch Med, Baltimore, MD USA

[3] Univ Utah, Div Rheumatol, Salt Lake City, UT USA

[4] Salt Lake VAMC, Salt Lake City, UT USA

[5] Univ Pittsburgh, Pittsburgh, PA USA

[6] Rutgers RWJ Med Sch, South Plainfield, NJ USA

[7] Univ Calif Los Angeles, Los Angeles, CA USA

[8] Univ Texas Houston, Houston, TX USA

[9] Boston Univ, Boston, MA 02215 USA

[10] Corbus Pharmaceut, Norwood, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0865

引用

页数：3